SecBot SecBot
SECBOTREPLAY Home › Report › PHGE

PHGE · BiomX filed an 8-K posting an updated investor presentation detailing…

BiomX Inc. · 8-K filed Jun 18, 2026 at 09:20 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jun 18, 2026 at 09:20 ET

BiomX filed an 8-K posting an updated investor presentation detailing its completed strategic transition from clinical-stage biotech to a defense and security technology holding company. The presentation describes its portfolio (Zorronet AI C5ISR platform and DFSL LADAR detection), leadership, and growth strategy but provides no financial data, revenue, or guidance. This is a routine informational update with no material new financial information.

  • BiomX has completed its strategic transition from clinical-stage biotech to a defense and security technology holding company.
  • The portfolio includes Zorronet (AI-powered Autonomous Command Center platform, 100% owned) and DFSL (LADAR-based threat detection, 60% owned).
  • The presentation highlights leadership with experience from Mossad, Elbit Systems, and IDF, and an advisory board including a former Deputy Head of the Mossad.
  • The company acknowledges a going-concern qualification in its financial statements and is focused on implementing its NYSE American compliance plan.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access